1. Home
  2. PHGE vs OMH Comparison

PHGE vs OMH Comparison

Compare PHGE & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$2.21

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.84

Market Cap

17.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHGE
OMH
Founded
2015
2015
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
17.6M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
PHGE
OMH
Price
$2.21
$0.84
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$26.00
N/A
AVG Volume (30 Days)
125.5K
43.4K
Earning Date
11-12-2025
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,264,748.00
Revenue This Year
N/A
$28.40
Revenue Next Year
N/A
$23.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
78.86
52 Week Low
$1.50
$0.59
52 Week High
$22.06
$4.93

Technical Indicators

Market Signals
Indicator
PHGE
OMH
Relative Strength Index (RSI) 50.66 47.55
Support Level $1.81 $0.80
Resistance Level $2.28 $0.84
Average True Range (ATR) 0.22 0.06
MACD -0.04 0.01
Stochastic Oscillator 81.11 39.77

Price Performance

Historical Comparison
PHGE
OMH

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: